No Detail Found!

Comparison of Suprachoroidal Injection of Triamcinolone Acetonide Versus Intravitreal Bevacizumab in Primary Diabetic Macular Odema

Author(s)
FAISAL ANWAR Department of Ophthalmology, King Edward Medical University, Mayo Hospital,Lahore,Pakistan
ASAD ASLAM KHAN Department of Ophthalmology, King Edward Medical University, Mayo Hospital,Lahore,Pakistan
TEHSEEN MAHMOOD MAJHU Department of Ophthalmology, King Edward Medical University, Mayo Hospital,Lahore,Pakistan
RANA MOHAMMAD MOHSIN JAVAID King Edward Medical University, Mayo Hospital,Lahore,Pakistan
MUHAMMAD TAHIR GHAFFAR Department of Ophthalmology, King Edward Medical University, Mayo Hospital,Lahore,Pakistan
MOHAMMAD HASAN BOKHARI Department of Ophthalmology, King Edward Medical University, Mayo Hospital,Lahore,Pakistan
Abstract
Objective: Present study aims to compare the efficacy of single dose triamcinolone acetonide suspension in suprachoroidal space and intravitreal bevacizumab in primary diabetic macular edema patients. Study design: Prospective observational study Study duration and settings: Study was conducted at department of ophthalmology, Eye Unit III, Mayo hospital Lahore (KEMU) from March 2020 to August 2020. Material and methods: The WHO calculator was used to estimate a sample size of 136 patients (66 patients in each group). Non-probability sequential sampling was used to identify patients.. Intravitreal bevacizumab injections (2.5 mg/0.1 mL) were given to patients in Group A, and triamcinolone acetonide was given to patients in Group B, all at random. After one and three months, patients were reassessed. Results: Total 135 patients were included in study. There were 71(52.2%) male and 65(47.8%) female. Mean age of patients was 41.1±6.9SD. BCVA improved 5 letters after 3 month was significantly high in TA group as compared to IVB (P=0.002). Moreover, CSF decreased at least 10% from baseline after one and three months was comparatively high in TA group (p=0.01 and p=0.04 respectively). Among all the patients in IVB group, 29.5% showed efficacy while in group TA, 37.5% showed efficacy (p=0.03) Conclusion: Triamcinolone acetonide is an efficient drug for management of diabetic macular edema. Triamcinolone had long standing effect as compared to intravitreal bevacizumab on structural and functional outcome of the patients with primary diabetic macular odema. Both interventions are associated with limited complications.
Publication Details
Page(s) 304-306
Published Journal: Pakistan Journal of Medical and Health Sciences, Volume: 16, Issue: 06, Year: 2022

Request the full text from PASTIC

Keywords
triamcinolone acetonide, Diabetic macular edema, Intravitral bevacizumab
References
Klein R,Knudtson MD,Lee KE,Gangnon R,Klein BE,-1868 Zhang X,Zeng H,Bao S,Wang N,Gillies MC .2016 .Diabetic macular edema: new concepts in patho-physiology and treatment. Cell Biosci, 4(3) : 27.
Hakeem R,Fawwad A,Bhagat N,Grigorian RA,Tutela A,Zarbin MA .2019 .Diabetic macular edema: pathogenesis and treatment. Surv Ophthalmol, 54(1) : 1-32.
Funatsu H,Noma H,Mimura T,Eguchi S,Hori S.,Pognuz R,Polito A,Pirracchio A,Menchini F,Ambesi M. .2016 .Association of vitreous inflammatory factors with diabetic macular edema. Ophthalmology, 116(1) : 73-79.
Zhang X,Bao S,Lai D,Rapkins RW,Gillies MC .2018 .Intravitreal triamcinolone acetonide inhibits breakdown of the blood-retinal barrier through differential regulation of VEGF-A and its receptors in early diabetic rat retinas. Diabetes, 57(4) : 1026-1033.
Ghoraba HH,Leila M,Elgouhary SM,Elgemai EEM,Abdelfattah HM,Ghoraba HH,Tayyab H,Ahmed N H,Sadiq A.A.M. H .2020 .Efficacy and safety of Suprachoroidal Triamcinolone Acetonide in cases of resistant diabetic Macular Edema. Pak J Med Sci, 36(2) : 42-47.
Goldstein DA,Do D,Noronha G,Kissner JM,Srivastava SK,Nguyen QD .2016 .Suprachoroidal Corticosteroid Administration:A Novel Route for Local Treatment of Noninfectious Uveitis. Transl Vis Sci Technol, 5(6) : 14.
Fong DS,Ferris FL,Davis MD,Chew EY .1999 .Causes of severe visual loss in the early treatment diabetic retinopathy study. ETDRS report no. 24. Early Treatment Diabetic Retinopathy Study Research Group. Am J Ophthalmol, 127(2) : 137-141.
Striph GG,Hart WM .1988 .Modified grid laser photocoagulation for diabetic macular edema. The effect on the central visualfield. Ophthalmology, 95(12) : 1673-1679.
Lim JW,Lee HK,Shin MC .2012 .Comparison of intravitreal bevacizumab alone or combined with triamcinolone versus triamcinolone in diabetic macular edema: a randomized clinical trial. Ophthalmologica, 227(2) : 100-106.
Song HJ,Lee JJ,Lee SJ .2011 .Comparison of the Short-Term Effects of IVTA and Bevacizumab Injection for Diabetic Macular Edema. Korean J Ophthalmol, 25(3) : 156-160.
Isaac DL,Abud MB,Frantz KA,Rassi AR,Avila M. Comparing,Sutter FK,Simpson JM,Gillies MC .2004 .Intravitreal triamcinolone for diabetic macular edema that persists after laser treatment: three month efficacy and safety results of a prospective, randomized, double-masked, placebo-controlled clinical trial. Ophthalmology, 111(11) : 2044-2049.
.2008 .Intravitreal triamcinolone versus bevacizumab for treatment of refractory diabetic macular oedema (IBEME study) Br J Ophthalmol. , 92(1) : 76-80.
Ophir A ,Kreutzer TC,Al Saeidi R,Kook D,Wolf A,Ulbig MW,Neubauer AS,Haritoglou C .2010 .Comparison of intravitreal bevacizumab versus triamcinolone for the treatment of diffuse diabetic macular edema. Ophthalmologica, 224(4) : 258-264.
.2013 .Intravitreal triamcinolone versus intravitreal bevacizumab for diabetic macular edema: a meta-analysis. Int J Ophthalmol, 6(4) : 546-552.
Christoforidis JB,Carlton MM,Knopp MV,Hinkle GH,Shimura M,Nakazawa T,Yasuda K,Shiono T,Lida T,Sakamoto T,Nishida K. .2008 .Comparative therapy evaluation of intravitreal bevacizumab and triamcinolone acetonide on persistent diffuse diabetic macular edema. Am J Ophthalmol, 145(5) : 854-861.
Marey HM,Ellakwa AF .2011 .Intravitreal bevacizumab alone or combined with triamcinolone acetonide as the primary treatment for diabetic macular edema. Clin Ophthalmol, 5 : 1011-1016.
0

Citations

0

Downloads

103

Views